Progastricsin also known as pepsinogen C or pepsinogen II is a pepsinogen precursor of the enzyme gastricsin that in humans is encoded by the PGCgene.[1][2][3][4]
Function
Progastricsin is an aspartic proteinase that belongs to the peptidase family A1. The encoded protein is a digestive enzyme that is produced in the stomach and constitutes a major component of the gastric mucosa. This protein is also secreted into the serum. This protein is synthesized as an inactive zymogen that includes a highly basic prosegment. This enzyme is converted into its active mature form at low pH by sequential cleavage of the prosegment that is carried out by the enzyme itself.[4]
Clinical significance
Polymorphisms in this gene are associated with susceptibility to gastric cancers. Serum levels of this enzyme are used as a biomarker for certain gastric diseases including Helicobacter pylori related gastritis.[4]
^Pals G, Azuma T, Mohandas TK, Bell GI, Bacon J, Samloff IM, Walz DA, Barr PJ, Taggart RT (February 1989). "Human pepsinogen C (progastricsin) polymorphism: evidence for a single locus located at 6p21.1-pter". Genomics. 4 (2): 137–48. doi:10.1016/0888-7543(89)90292-9. PMID2567697.
Athauda SB, Tanji M, Kageyama T, Takahashi K (1990). "A comparative study on the NH2-terminal amino acid sequences and some other properties of six isozymic forms of human pepsinogens and pepsins". J. Biochem. 106 (5): 920–7. doi:10.1093/oxfordjournals.jbchem.a122952. PMID2515193.
Westerveld BD, Pals G, Bosma A, et al. (1987). "Gastric proteases in Barrett's esophagus". Gastroenterology. 93 (4): 774–8. doi:10.1016/0016-5085(87)90439-2. PMID3305135.
Moore SA, Sielecki AR, Chernaia MM, et al. (1995). "Crystal and molecular structures of human progastricsin at 1.62 A resolution". J. Mol. Biol. 247 (3): 466–85. doi:10.1006/jmbi.1994.0154. PMID7714902.
Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID8125298.
Aabakken L, Axelsson CK, Szecsi PB (1993). "Pepsinogen A and C serum levels in relation to acute NSAID-associated mucosal lesions in healthy volunteers". Scand. J. Gastroenterol. 28 (6): 557–60. doi:10.3109/00365529309098266. PMID8322031.
Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID9373149.
Khan AR, Cherney MM, Tarasova NI, James MN (1998). "Structural characterization of activation 'intermediate 2' on the pathway to human gastricsin". Nat. Struct. Biol. 4 (12): 1010–5. doi:10.1038/nsb1297-1010. PMID9406551. S2CID26283922.